We are live on ! Find out more
VYNT

Vyant Bio, Inc. Common Stock
VYNT

Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

27 hedge funds and large institutions have $3.12M invested in Vyant Bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

17% more funds holding

Funds holding: 23 → 27 (+4)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

41% less capital invested

Capital invested by funds: $5.27M → $3.12M (-$2.14M)

Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$96.5K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.9K
3
AWM
AE Wealth Management
Kansas
+$22.2K
4
UBS Group
UBS Group
Switzerland
+$20.6K
5
Millennium Management
Millennium Management
New York
+$15.2K

Top Sellers

Rank Fund Capital Flow
1
TWMP
Taylor Wealth Management Partners
Massachusetts
-$70.1K
2
Renaissance Technologies
Renaissance Technologies
New York
-$26.3K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$2.29K
4
Osaic Holdings
Osaic Holdings
Arizona
-$1K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.15M -$2.29K -224 -0.1%
BlackRock
2
BlackRock
New York
$288K +$6.56K +641 +2%
BF
3
Blankinship & Foster
California
$277K – – –
FWM
4
Frontier Wealth Management
Missouri
$274K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$254K – – –
Cerity Partners
6
Cerity Partners
New York
$161K – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$130K -$26.3K -2,572 -12%
State Street
8
State Street
Massachusetts
$89K – – –
TWMP
9
Taylor Wealth Management Partners
Massachusetts
$65K -$70.1K -6,850 -42%
VF
10
Virtu Financial
New York
$64K +$96.5K +9,427 New
Northern Trust
11
Northern Trust
Illinois
$59K – – –
JMPWA
12
JP Morgan Private Wealth Advisors
California
$55K – – –
Morgan Stanley
13
Morgan Stanley
New York
$51K – – –
JSC
14
Jackson Square Capital
California
$41K – – –
Millennium Management
15
Millennium Management
New York
$32K +$15.2K +1,486 +46%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$31K +$46.9K +4,580 New
CCT
17
Country Club Trust
Missouri
$28K – – –
NP
18
NorthRock Partners
Minnesota
$25K – – –
CCM
19
Carlson Capital Management
Minnesota
$16K – – –
AWM
20
AE Wealth Management
Kansas
$15K +$22.2K +2,167 New
UBS Group
21
UBS Group
Switzerland
$14K +$20.6K +2,008 New
TRCT
22
Tower Research Capital (TRC)
New York
$5K +$1.2K +117 +17%
US Bancorp
23
US Bancorp
Minnesota
$1K – – –
Osaic Holdings
24
Osaic Holdings
Arizona
– -$1K -80 Closed
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
– -$1K -51 Closed
1
2

VYNT Hedge Fund Activity: Q4 2021 in Review

27 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q4 2021, worth a combined $3.12M — down 41% from $5.27M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VYNT positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $96.5K. The largest seller was Taylor Wealth Management Partners, cutting an estimated $70.1K.

  • 27 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q4 2021, up from 23 in Q3 2021.
  • Funds reported $3.12M of Vyant Bio, Inc. Common Stock stock for Q4 2021, down 41% quarter-over-quarter.
  • 6 funds opened new Vyant Bio, Inc. Common Stock positions in Q4 2021 and 2 closed out, a net change of +4 holders.
  • The largest Vyant Bio, Inc. Common Stock buyer in Q4 2021 was Virtu Financial, an estimated $96.5K added.
  • The largest Vyant Bio, Inc. Common Stock seller in Q4 2021 was Taylor Wealth Management Partners, an estimated $70.1K sold.

Based on aggregated 13F filings for Q4 2021.